Sarborg Limited has assembled a proprietary database exceeding 850 coformers, positioning the company to apply quantum computing to the complex process of solid-form development through its newly launched division, SarborgQ. CDT Equity Inc. highlights this initiative as a practical application of quantum technology, potentially accelerating the creation of intellectual property and improving development efficiency within Sarborg’s existing portfolio and for future clients. The company intends to deploy these quantum-assisted tools to identify novel co-crystal and salt formations, aiming to create new patentable assets and enhance product offerings. “We are pleased to see Sarborg continuing to execute against its strategic roadmap and further expand the practical applications of its Signature Intelligence platform,” said Andrew Regan, Chief Executive Officer of CDT Equity, emphasizing the potential to strengthen the commercial value of Sarborg’s assets.
SarborgQ Integrates Quantum Computing for Coformer Selection
Sarborg Limited is actively integrating quantum computing into its solid-form development processes, a move that may accelerate intellectual property creation within the pharmaceutical sector. SarborgQ, the newly launched dedicated quantum computing division, is central to this effort, leveraging a substantial proprietary database of over 850 coformers for analysis. This curated resource provides a significant foundation for applying quantum algorithms to the complex task of coformer selection, a critical step in optimizing drug formulation and bioavailability. SarborgQ’s focus is specifically on enhancing solid-form development, indicating a targeted investment in practical applications. The company’s approach combines these coformer datasets with emerging quantum computing capabilities, aiming to improve decision-making and identify novel solid-form opportunities like co-crystals and salts.
Sarborg intends to initially apply these quantum-assisted tools to its own intellectual property portfolio, seeking to generate new patentable assets and improve existing products before extending the service to external partners. This strategy suggests a phased implementation, beginning with internal optimization before offering the technology as a commercial service for formulation development programs. CDT Equity, a stakeholder in Sarborg, believes this initiative represents development of Sarborg’s Signature Intelligence platform. According to CDT, applying quantum computing and agentic reasoning to solid-form development has the “potential to accelerate intellectual property generation, improve development efficiency and expand the commercial opportunities” available to Sarborg.
The application of SarborgQ to solid-form development demonstrates how Sarborg is seeking to leverage quantum computing to accelerate intellectual property generation and strengthen the commercial potential of its existing asset portfolio, whilst also creating opportunities to support third-party development programmes.
Andrew Regan, Chief Executive Officer of CDT Equity
